SCHEMBL14725705

SCHEMBL14725705

c1ccc(-n2c3ccccc3c3c4c(-c5ccc6oc7ccccc7c6c5)cc5cc6c(cc(-c7ccc8oc9ccccc9c8c7)c7c6ccc6c7c7ccccc7n6-c6ccccc6)cc5c4ccc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.34
▸ SIRT1 Q96EB6 1/20 0.34
▸ SMN1; SMN2 Q16637 5/20 0.34
▸ LMNA P02545 2/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ CHEK2 O96017 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14725699 0.87 L3MBTL1 (0.46) KDM4EATML3MBTL1ALDH1A1MEN1
SCHEMBL26214982 0.85 KDM4E (0.45) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL14725732 0.85 KDM4E (0.39) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL25775454 0.84 KDM4E (0.40) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL15759572 0.84 KDM4E (0.44) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL15759542 0.84 KDM4E (0.44) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL14725682 0.84 L3MBTL1 (0.46) KDM4EATML3MBTL1ALDH1A1MEN1
SCHEMBL16574980 0.83 KDM4E (0.42) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL24362785 0.83 KDM4E (0.42) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL14725708 0.83 ALOX5 (0.40) KDM4EATML3MBTL1SIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255084-B2 Heterocyclic compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-02-09 — — US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 — — US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME TRPC1, TRPC4, TRPC6 KDM4E 1981/4885ATM 4059/4885L3MBTL1 1029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback